Trial Outcomes & Findings for Smoking Termination Enhancement Project (STEP) (NCT NCT01065506)

NCT ID: NCT01065506

Last Updated: 2016-02-04

Results Overview

Point Prevalence Abstinence (PPA) was defined as not smoking \[even a single puff\] at the end of treatment and/or on the day of follow-up

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

150 participants

Primary outcome timeframe

End of treatment (10 weeks post quit day) and 30-week follow-up

Results posted on

2016-02-04

Participant Flow

Of the 150 enrolled participants, 7 participants completed a baseline assessment, then subsequently dropped out of the study before receiving any treatment. 7 participants were used as pilots. Accordingly, results are reported for the remaining 136 participants.

Participant milestones

Participant milestones
Measure
Standard Care Plus Wellness Program
Cognitive Behavioral Treatment: Cognitive Behavioral Treatment Nicotine Patch: Nicotine Patch Wellness Program: Wellness Program consisting of thrice weekly sessions involving discussion of various wellness topics (e.g., diet, sun care, cancer prevention) and generating small wellness-related goals
Standard Care Plus Exercise Program
Cognitive Behavioral Treatment: Cognitive Behavioral Treatment Nicotine Patch: Nicotine Patch Aerobic Exercise: Aerobic Exercise thrice weekly (on a treadmill)
Overall Study
STARTED
64
72
Overall Study
End of Treatment
44
37
Overall Study
4-Month Follow-Up
35
34
Overall Study
COMPLETED
32
34
Overall Study
NOT COMPLETED
32
38

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Smoking Termination Enhancement Project (STEP)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard Care Plus Wellness Program
n=64 Participants
Cognitive Behavioral Treatment: Cognitive Behavioral Treatment Nicotine Patch: Nicotine Patch Wellness Program: Wellness Program
Standard Care Plus Exercise Program
n=72 Participants
Cognitive Behavioral Treatment: Cognitive Behavioral Treatment Nicotine Patch: Nicotine Patch Aerobic Exercise: Aerobic Exercise
Total
n=136 Participants
Total of all reporting groups
Age, Continuous
45.39 years
STANDARD_DEVIATION 11.30 • n=5 Participants
43.12 years
STANDARD_DEVIATION 11.26 • n=7 Participants
44.19 years
STANDARD_DEVIATION 11.29 • n=5 Participants
Sex: Female, Male
Female
36 Participants
n=5 Participants
36 Participants
n=7 Participants
72 Participants
n=5 Participants
Sex: Female, Male
Male
28 Participants
n=5 Participants
36 Participants
n=7 Participants
64 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
10 Participants
n=5 Participants
18 Participants
n=7 Participants
28 Participants
n=5 Participants
Race (NIH/OMB)
White
49 Participants
n=5 Participants
51 Participants
n=7 Participants
100 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
n=5 Participants
2 Participants
n=7 Participants
5 Participants
n=5 Participants
Region of Enrollment
United States
64 participants
n=5 Participants
72 participants
n=7 Participants
136 participants
n=5 Participants
ASI-3
18.63 units on a scale
STANDARD_DEVIATION 10.36 • n=5 Participants
18.04 units on a scale
STANDARD_DEVIATION 12.72 • n=7 Participants
18.32 units on a scale
STANDARD_DEVIATION 11.62 • n=5 Participants

PRIMARY outcome

Timeframe: End of treatment (10 weeks post quit day) and 30-week follow-up

Population: Participants who completed the end of treatment assessment

Point Prevalence Abstinence (PPA) was defined as not smoking \[even a single puff\] at the end of treatment and/or on the day of follow-up

Outcome measures

Outcome measures
Measure
Standard Care Plus Wellness Program
n=44 Participants
Cognitive Behavioral Treatment: Cognitive Behavioral Treatment Nicotine Patch: Nicotine Patch Wellness Program: Wellness Program
Standard Care Plus Exercise Program
n=37 Participants
Cognitive Behavioral Treatment: Cognitive Behavioral Treatment Nicotine Patch: Nicotine Patch Aerobic Exercise: Aerobic Exercise
Percentage of Participants Who Abstained From Smoking at 10 and 30 Weeks Post Quit Day
End of treatment
5 number of participants
9 number of participants
Percentage of Participants Who Abstained From Smoking at 10 and 30 Weeks Post Quit Day
Follow-up (n=35, 34)
4 number of participants
9 number of participants

Adverse Events

Standard Care Plus Wellness Program

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard Care Plus Exercise Program

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Standard Care Plus Wellness Program
n=64 participants at risk
Cognitive Behavioral Treatment: Cognitive Behavioral Treatment Nicotine Patch: Nicotine Patch Wellness Program: Wellness Program
Standard Care Plus Exercise Program
n=72 participants at risk
Cognitive Behavioral Treatment: Cognitive Behavioral Treatment Nicotine Patch: Nicotine Patch Aerobic Exercise: Aerobic Exercise
Skin and subcutaneous tissue disorders
Malignant melanoma
0.00%
0/64
1.4%
1/72 • Number of events 1
Musculoskeletal and connective tissue disorders
Vertebrae fractures
1.6%
1/64 • Number of events 1
0.00%
0/72

Other adverse events

Adverse event data not reported

Additional Information

Jasper Smits

The University of Texas at Austin

Phone: 512-475-8095

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place